Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Solifebuvir and Ledipasvir

Generic Name: Solifebuvir and Ledipasvir

Overview

No overview information available.

Background

No background information available.

Indication

用于治疗丙型肝炎(简称丙肝)病毒感染。尤其适用在成年中为慢性丙肝(CHC)基因型1感染的治疗。

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study of Sofosbuvir and Ledipasvir From Soviredia 90/400 mg Tablets (Minapharm, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)

Phase 1

Completed

Posted: 2019/07/31

Sponsor:

Genuine Research Cen...

ID:NCT04039958

Harvoni Treatment Porphyria Cutanea Tarda

Phase 2

Completed

Posted: 2017/04/18

Sponsor:Wake Forest Universi...

ID:NCT03118674

A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)

Phase 1

Completed

Posted: 2016/12/29

Sponsor:

Genuine Research Cen...

ID:NCT03005210

Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World

Phase 4

Completed

Posted: 2016/11/15

Sponsor:Partners in Health

ID:NCT02964091

Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia

Phase 2

Completed

Posted: 2016/07/07

Sponsor:Icahn School of Medi...

ID:NCT02825212

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy